This online course is part of a longer line of research methodology which is aimed at providing interested participants with information about the preclinical development and clinical translation, as well as the design, conductance and reporting of clinical research trials, with a specific emphasis on radiopharmaceuticals for both diagnostic and therapeutic applications. Learning Objectives For […]
This online course offers a comprehensive introduction to alpha therapy in nuclear medicine, with a focus on the fundamental principles and clinical applications of Alpha-Therapy in the fields of Radiopharmaceutical Sciences, Oncology and Dosimetry. Alpha Therapy is a cutting-edge cancer treatment using alpha radiation. It represents a form of targeted radionuclide therapy that uses alpha-emitting […]
New ESMIT Learning format: Self-paced online course followed by a live session with the course faculty, where participants are able to ask their questions live!* Nuclear Medicine Essentials: The Basics of MSK provides a comprehensive introduction to musculoskeletal applications in nuclear medicine, focusing on both diagnostic and therapeutic techniques. Participants will explore the fundamental principles of […]
This course has been accredited with 3 CME credits by the UEMS EACCME. Radiolabelled prostate-specific membrane antigen (PSMA) is increasingly used in imaging and treatment of prostate cancer. PSMA-directed radionuclide therapy is an efficacious new treatment option in patients with metastatic castration-resistant prostate cancer (mCRPC) and beyond. The online course will cover the spectrum of radiolabelled […]
Alzheimer’s disease is a growing global health concern, now facing a pivotal moment with the approval of disease-specific treatments. This Focus Meeting brought together international experts under the theme ‘An accurate diagnosis for an effective treatment with Molecular Imaging’ to explore the crucial role of imaging and biomarkers in improving diagnosis, treatment selection, and monitoring. The goal […]
Targeted Radionuclide Therapy (TRT) is an expanding field of cancer treatment in which radiopharmaceuticals—comprising a radionuclide linked to a tumour-targeting biological vector—are administered to deliver cytotoxic radiation doses selectively to malignant tissues. The growing development of theragnostic agents, enabling both imaging and therapy, has strengthened the rationale for a patient-specific treatment approach. In clinical trials, […]
This presentation provides an overview of fibroblast activation protein (FAP)–directed molecular imaging as a novel approach for tumour staging and theranostic decision-making across multiple malignancies. It introduces the biological role of cancer-associated fibroblasts and stromal remodeling in tumour progression and highlights the rationale for FAP-targeted PET imaging. Clinical evidence from prospective trials and comparative imaging […]